Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 2023 Bethesda System for Reporting Thyroid Cytopathology.
Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. Ali SZ, et al. Among authors: cochand priollet b. Thyroid. 2023 Sep;33(9):1039-1044. doi: 10.1089/thy.2023.0141. Epub 2023 Jul 8. Thyroid. 2023. PMID: 37427847
The 2023 Bethesda System for reporting thyroid cytopathology.
Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. Ali SZ, et al. Among authors: cochand priollet b. J Am Soc Cytopathol. 2023 Sep-Oct;12(5):319-325. doi: 10.1016/j.jasc.2023.05.005. Epub 2023 Jul 10. J Am Soc Cytopathol. 2023. PMID: 37438235
Cell block practices in European cytopathology laboratories.
Srebotnik Kirbis I, Kholova I, Huhtala H, Bongiovanni M, Strojan Flezar M, Hodgson C, Cochand-Priollet B. Srebotnik Kirbis I, et al. Among authors: cochand priollet b. Cancer Cytopathol. 2024 Apr;132(4):250-259. doi: 10.1002/cncy.22793. Epub 2024 Feb 7. Cancer Cytopathol. 2024. PMID: 38324231
Response to Letter to the Editor From Jagannath and Mayilvaganan: "FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography".
Koumakis E, Gauthé M, Martinino A, Sindayigaya R, Delbot T, Wartski M, Clerc J, Roux C, Borderie D, Cochand-Priollet B, Cormier C, Gaujoux S. Koumakis E, et al. Among authors: cochand priollet b. J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1318-e1319. doi: 10.1210/clinem/dgad615. J Clin Endocrinol Metab. 2024. PMID: 37846771 No abstract available.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
Lebret T, Paoletti X, Pignot G, Roumiguié M, Colombel M, Savareux L, Verhoest G, Guy L, Rigaud J, De Vergie S, Poinas G, Droupy S, Kleinclauss F, Courtade-Saïdi M, Piaton E, Radulescu C, Rioux-Leclercq N, Kandel-Aznar C, Renaudin K, Cochand-Priollet B, Allory Y, Nivet S, Rouprêt M. Lebret T, et al. Among authors: cochand priollet b. World J Urol. 2023 Sep;41(9):2381-2388. doi: 10.1007/s00345-023-04519-4. Epub 2023 Jul 22. World J Urol. 2023. PMID: 37480491 Free PMC article.
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.
Talbot JN, Périé S, Tassart M, Delbot T, Aveline C, Zhang-Yin J, Kerrou K, Gaujoux S, Wagner I, Bennis M, Ménégaux F, Breton S, Cochand-Priollet B, Christin-Maitre S, Groussin L, Haymann JP, Baujat B, Balogova S, Montravers F. Talbot JN, et al. Among authors: cochand priollet b. Q J Nucl Med Mol Imaging. 2023 Jun;67(2):96-113. doi: 10.23736/S1824-4785.23.03513-6. Epub 2023 Mar 30. Q J Nucl Med Mol Imaging. 2023. PMID: 36995286 Free article.
161 results